Key result
Subclinical atherosclerosis (CAC score >0) was identified in 21.8% of asymptomatic young adults and was significantly associated with age, male gender, diabetes, hypertension, and dyslipidaemia.
Why the study?
What is the prevalence of coronary artery calcification in asymptomatic young adults and its association with cardiovascular risk factors?
Cross-Sectional (n=4,186)
No
What is the prevalence of coronary artery calcification in asymptomatic young adults and its association with cardiovascular risk factors?
Subclinical atherosclerosis (CAC > 0) is present in approximately 20% of asymptomatic young adults (≤45 years) and is strongly associated with traditional cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Prevalence of subclinical atherosclerosis in asymptomatic young adults underscores risk factor assessment; leaves open whether CAC screening improves outcomes.
Coronary atherosclerosis is a continuous process beginning early in life, with a long and clinically asymptomatic phase, before manifestations appear in middle and/or late adulthood.1–3 Coronary artery calcification (CAC) is a well-established marker of atherosclerosis;4–8 nonetheless, the clinical validity of CAC in young adults – traditionally considered as a population group of low cardiovascular risk – remains unclear. We aimed to assess the prevalence of CAC in a population of young individuals without previous history of coronary artery disease (CAD) in the UK and its association with conventional cardiovascular risk factors. This analysis includes 4186 asymptomatic young individuals who underwent electron beam computed tomography (EBCT) at European Scanning Centre (London, UK) between January 2002 and December 2009 as part of a preventive healthcare examination. Demographic information and the presence of cardiovascular risk factors were abstracted from referral letters and/or questionnaires completed by the patients prior to their tests. Individuals with previously documented CAD or chronic kidney disease were excluded. All EBCT CAC studies were performed using the same scanner (Imatron C300 Ultrafast computed tomography scanner, GE Healthcare, London, UK) and the same scanning protocol. The age (mean ± SD) of the study cohort was 40.5 ± 3.6 years (range 26–45 years, 83.8% males). The majority (81.6%) of this cohort was Caucasians, followed by South Asians (8%). Hypertension, dyslipidaemia, and diabetes mellitus (DM) were present in 15.5, 7.9, and 2.8% of individuals, respectively. Family history of premature CAD was present in 17%, while 17.4% were smokers. The proportion of individuals with hypertension and dyslipidaemia increased with increasing age, while the prevalence of smoking and that of a positive family history for CAD decreased (Table 1). Clinical characteristics and proportion of CAC scores according to age groups Values are mean ± SD or %. BMI, body mass index; CAC, coronary artery calcification; DM, diabetes mellitus; FH, family history of premature coronary heart disease. Clinical characteristics and proportion of CAC scores according to age groups Values are mean ± SD or %. BMI, body mass index; CAC, coronary artery calcification; DM, diabetes mellitus; FH, family history of premature coronary heart disease. Overall, CAC was present in 21.8% of the cohort, while individuals with CAC comparing with those with CAC score 0 were males (95.2 vs. 80%, p < 0.002), older in age (41.4 ± 3.2 vs. 40.3 ± 3.7 years, p < 0.0001), with DM (5.5 vs. 25%, p < 0.0001), hypertension (22 vs. 13.7%, p < 0.0001), and dyslipidaemia (14.8 vs. 6%, p < 0.0001). The prevalence of CAC score 0, 1–100, 101–400, 401–1000, >1000 were 78.2, 19, 2.1, 0.5, and 0.2%, respectively. The prevalence and distribution of CAC among various age groups are shown in Table 1. CAC was found in 24.8% of males (CAC score 1–100, 101–400, 400–1000, >1000 in 21.6, 2.5, 0.5, and 0.1%, respectively) and 6.6% of females (CAC score 1–100, 101–400, 400–1000, >1000 in 5.4, 0.6, 0.15 and 0.4%, respectively) (p < 0.0001). There was no statistical difference of mean CAC score between genders (males 13.8 ± 72.7; females 11.8 ± 142.4; p = 0.6). In multivariate analysis, the presence of CAC was associated with age (p < 0.0001), male gender (p < 0.0001), DM (p < 0.0001), hypertension (p < 0.0001), and dyslipidaemia (p < 0.0001). In conclusion, in a large cohort of asymptomatic young individuals, subclinical atherosclerosis (CAC score >0) was identified in ∼20%. There was a male preponderance. Assessment of CAC score is a useful clinical tool in young individuals, as it can confirm the presence of subclinical atherosclerosis. In this way, the abnormal levels of calcium may place individuals into a higher risk group in terms of future events and lead to more aggressive treatment with preventative therapies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare that there is no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Koulaouzidis et al. (2013) conducted a cross-sectional in Asymptomatic young individuals without previous history of CAD (n=4,186). Cardiovascular risk factors was evaluated on Presence of coronary artery calcification (CAC score >0). Subclinical atherosclerosis (CAC score >0) was identified in 21.8% of asymptomatic young adults and was significantly associated with age, male gender, diabetes, hypertension, and dyslipidaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: